Pancratic head vs pancreatic body/tail:into which region should a prophylactic pacreatic stent inserted in high risk patients: Randomized Controlled Trial
Not Applicable
Recruiting
- Conditions
- High risk patient for post-ERCP pancreatitis (PEP)
- Registration Number
- JPRN-UMIN000042395
- Lead Sponsor
- Department of Gastroenterology, Fukushima Medical University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Vater papilla that has already performed endoscopic procedures (EST, stenting, EPBD, etc) 2. The imposiblity of endoscopic access to Vater papilla 3. The past history of gastorectomy 4. Pancreas divism 5. Intraductal papillary mucinous neoplasm 6. Theraperutic pancreatic stent insertion 7. Chronic pancreatitis, pancreatic head cancer 8. Postampllectomy 9. Malfusion of pancreaticobiliary ducts 10. Allergies to drugs that are used in ERCP 11. Acute pancreatitis, or serum hyperamylasemia (pancratic isozyme more than 150 IU/L) 12. Not sufficiently sedated
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method